Algert Global LLC Agenus Inc Transaction History

Algert Global LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$1.96 - $3.14 $40,395 - $64,715	20,610 Added 23.05%	110,006 $226,000
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $86,515 - $127,748	36,815 Added 70.02%	89,396 $220,000
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $67,043 - $131,790	22,960 Added 77.51%	52,581 $169,000
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $147,512 - $196,387	29,621 New	29,621 $156,000
Q4 2020 Feb 12, 2021	SELL	$3.17 - $4.49 $85,431 - $121,005	-26,950 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.98 - $5.2 $80,311 - $140,140	26,950 New	26,950 $108,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.